Unjha Formulations Shows Strong Growth in Q1 2024 Financial Results
Unjha Formulations, a microcap pharmaceutical company, has reported a positive performance in the quarter ending March 2024 with a score improvement from 6 to 8. The company's net sales have grown by 64.96% year on year, indicating a strong sales trend. Its profitability has also improved, with a higher PAT in just half a year compared to the previous 12-month period. MarketsMojo has given a 'Hold' call for the company's stock, suggesting investors monitor its future performance before making any investment decisions.
Unjha Formulations, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending March 2024. The company has shown a positive performance in this quarter, with its score improving from 6 to 8 in the last 3 months according to MarketsMOJO.One of the key factors contributing to this improvement is the company's net sales, which have grown by 64.96% year on year to reach Rs 9.98 crore. This is a significant increase and indicates a strong sales trend in the near term for Unjha Formulations.
In terms of profitability, the company has also shown a positive trend. Its Profit After Tax (PAT) for the half-yearly period is higher at Rs 0.21 crore compared to the preceding 12-month period ending March 2024, which had a PAT of Rs -0.25 crore. This means that in just half a year, Unjha Formulations has already surpassed its PAT for the entire previous year.
Based on these financial results, MarketsMOJO has given a 'Hold' call for Unjha Formulations' stock. This indicates that while the company's performance is positive, it is not recommended as a strong buy or sell at this time. Investors may want to keep an eye on the company's future performance before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
